Cue Biopharma, Inc. (CUE)
0.4946
-0.03
(-6.38%)
USD |
NASDAQ |
Dec 09, 16:00
0.4753
-0.02
(-3.90%)
After-Hours: 07:17
Cue Biopharma Total Assets (Quarterly): 31.64M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Insmed, Inc. | 2.361B |
| Puma Biotechnology, Inc. | 202.86M |
| Mersana Therapeutics, Inc. | 62.69M |
| Adaptive Biotechnologies Corp. | 490.61M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.40M |
| Shareholders Equity (Quarterly) | 13.25M |
| Debt to Equity Ratio | 0.466 |
| Current Ratio | 1.663 |
| Net Debt Paydown Yield | 1.82% |